297 related articles for article (PubMed ID: 10939285)
1. Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.
Guillemin GJ; Smith DG; Kerr SJ; Smythe GA; Kapoor V; Armati PJ; Brew BJ
Redox Rep; 2000; 5(2-3):108-11. PubMed ID: 10939285
[TBL] [Abstract][Full Text] [Related]
2. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.
Guillemin GJ; Kerr SJ; Smythe GA; Smith DG; Kapoor V; Armati PJ; Croitoru J; Brew BJ
J Neurochem; 2001 Aug; 78(4):842-53. PubMed ID: 11520905
[TBL] [Abstract][Full Text] [Related]
3. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
4. Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons.
Guillemin GJ; Smythe G; Takikawa O; Brew BJ
Glia; 2005 Jan; 49(1):15-23. PubMed ID: 15390107
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
6. Expression of the kynurenine pathway enzymes in human microglia and macrophages.
Guillemin GJ; Smith DG; Smythe GA; Armati PJ; Brew BJ
Adv Exp Med Biol; 2003; 527():105-12. PubMed ID: 15206722
[TBL] [Abstract][Full Text] [Related]
7. Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway.
Fukuyama K; Tanahashi S; Hoshikawa M; Shinagawa R; Okada M
Neuropharmacology; 2014 Jan; 76 Pt A():137-45. PubMed ID: 23973311
[TBL] [Abstract][Full Text] [Related]
8. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
9. Role of the immune-kynurenine pathway in treatment-resistant schizophrenia.
Chen W; Tian Y; Gou M; Wang L; Tong J; Zhou Y; Feng W; Li Y; Chen S; Liu Y; Wang Z; Pan S; Zhang P; Huang J; Yang X; Li CR; Tian L; Hong LE; Tan Y
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Mar; 130():110926. PubMed ID: 38147973
[TBL] [Abstract][Full Text] [Related]
10. Kynurenine pathway in depression: A systematic review and meta-analysis.
Ogyu K; Kubo K; Noda Y; Iwata Y; Tsugawa S; Omura Y; Wada M; Tarumi R; Plitman E; Moriguchi S; Miyazaki T; Uchida H; Graff-Guerrero A; Mimura M; Nakajima S
Neurosci Biobehav Rev; 2018 Jul; 90():16-25. PubMed ID: 29608993
[TBL] [Abstract][Full Text] [Related]
11. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.
Heyes MP; Chen CY; Major EO; Saito K
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104
[TBL] [Abstract][Full Text] [Related]
12. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid.
Heyes MP; Achim CL; Wiley CA; Major EO; Saito K; Markey SP
Biochem J; 1996 Dec; 320 ( Pt 2)(Pt 2):595-7. PubMed ID: 8973572
[TBL] [Abstract][Full Text] [Related]
13. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications.
Ceresoli-Borroni G; Guidetti P; Amori L; Pellicciari R; Schwarcz R
J Neurosci Res; 2007 Mar; 85(4):845-54. PubMed ID: 17279543
[TBL] [Abstract][Full Text] [Related]
14. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
15. Kynurenine 3-Monooxygenase Activity in Human Primary Neurons and Effect on Cellular Bioenergetics Identifies New Neurotoxic Mechanisms.
Castellano-Gonzalez G; Jacobs KR; Don E; Cole NJ; Adams S; Lim CK; Lovejoy DB; Guillemin GJ
Neurotox Res; 2019 Apr; 35(3):530-541. PubMed ID: 30666558
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes in kynurenine pathway metabolites in multiple sclerosis: A systematic review.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Mohamadkhani A; Klegeris A; McElhinney A; Mafi Z; Hajiesmaeili M; Sayehmiri F
Front Immunol; 2022; 13():1013784. PubMed ID: 36426364
[TBL] [Abstract][Full Text] [Related]
17. IFN-beta1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment.
Guillemin GJ; Kerr SJ; Pemberton LA; Smith DG; Smythe GA; Armati PJ; Brew BJ
J Interferon Cytokine Res; 2001 Dec; 21(12):1097-101. PubMed ID: 11798468
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of kynurenine pathway metabolism in Toxoplasma gondii-infected mice: implications for schizophrenia.
Notarangelo FM; Wilson EH; Horning KJ; Thomas MA; Harris TH; Fang Q; Hunter CA; Schwarcz R
Schizophr Res; 2014 Jan; 152(1):261-7. PubMed ID: 24345671
[TBL] [Abstract][Full Text] [Related]
19. Kynurenic Acid Prevents Cytoskeletal Disorganization Induced by Quinolinic Acid in Mixed Cultures of Rat Striatum.
Pierozan P; Biasibetti-Brendler H; Schmitz F; Ferreira F; Pessoa-Pureur R; Wyse ATS
Mol Neurobiol; 2018 Jun; 55(6):5111-5124. PubMed ID: 28840509
[TBL] [Abstract][Full Text] [Related]
20. Kynurenate production by cultured human astrocytes.
Kiss C; Ceresoli-Borroni G; Guidetti P; Zielke CL; Zielke HR; Schwarcz R
J Neural Transm (Vienna); 2003 Jan; 110(1):1-14. PubMed ID: 12541009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]